Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Noskov

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
Psychopharmacology Bulletin|July 11, 2022
Correlation of <i>1846G</i>><i>A</i> Polymorphism of <i>CYP2D6</i> Gene with Haloperidol Efficacy and Safety in Patients with Alcoholic HallucinosesA A Parkhomenko, M S Zastrozhin, VYu Skryabin, et al.
Psychopharmacology Bulletin|November 7, 2022
Association of <b></b> Polymorphism with the Steady-State Concentration of Haloperidol in Patients with Alcohol-Induced Psychotic DisordersA A Parkhomenko, M S Zastrozhin, S A Pozdnyakov, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|January 12, 2026
[Experience of Relatox (botulinum toxin type A) using for chronic migraine treatment]Yu E Azimova, K V Skorobogatykh, D Z Korobkova, et al.
Psychopharmacology Bulletin|July 11, 2022
Influence of <i>CYP2C19*17</i> Genetic Polymorphism on the Steady-State Concentration of Escitalopram in Patients with Recurrent Depressive DisorderM S Zastrozhin, VYu Skryabin, F Rwere, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
Psychopharmacology Bulletin|July 11, 2022
Correlation of <i>1846G</i>><i>A</i> Polymorphism of <i>CYP2D6</i> Gene with Haloperidol Efficacy and Safety in Patients with Alcoholic HallucinosesA A Parkhomenko, M S Zastrozhin, VYu Skryabin, et al.
Psychopharmacology Bulletin|November 7, 2022
Association of <b></b> Polymorphism with the Steady-State Concentration of Haloperidol in Patients with Alcohol-Induced Psychotic DisordersA A Parkhomenko, M S Zastrozhin, S A Pozdnyakov, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|January 12, 2026
[Experience of Relatox (botulinum toxin type A) using for chronic migraine treatment]Yu E Azimova, K V Skorobogatykh, D Z Korobkova, et al.
Psychopharmacology Bulletin|July 11, 2022
Influence of <i>CYP2C19*17</i> Genetic Polymorphism on the Steady-State Concentration of Escitalopram in Patients with Recurrent Depressive DisorderM S Zastrozhin, VYu Skryabin, F Rwere, et al.
Pageof 3